Press release from the Kyoto University
The Kyoto university released a academic paper showing the pharmacokinetics and anticancer effects of highly safe water-soluble prodrug curcumin.
New research base, new address.
Our research base of THERABIOPHARMA is newly established in the Innovation Center East 604 inside the Kanagawa Science Park.
Our investigation results received media exposure
As collaborative research results with Kyoto University,Professor Masafumi Kanai (Graduate School of Medicine, Kyoto University ) announced the anticancer effect of the prodrug curcumin (CMG) at the 15th Annual Meeting of Japanese Society of Clinical Oncology Symposium (2017-7-27), . This content was also posted in the Yomiuri Newspaper the previous day and there was a big reaction.